BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35059351)

  • 21. Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review.
    Joshi MN; Whitelaw BC; Palomar MT; Wu Y; Carroll PV
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):331-9. PubMed ID: 26998595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nivolumab induced hypophysitis in an advanced RCC patient.
    Korkmaz Yilmaz M; Gulturk I; Tacar SY; Yilmaz M
    J Oncol Pharm Pract; 2022 Apr; 28(3):759-762. PubMed ID: 35006033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging findings in hypophysitis: a review.
    Caranci F; Leone G; Ponsiglione A; Muto M; Tortora F; Muto M; Cirillo S; Brunese L; Cerase A
    Radiol Med; 2020 Mar; 125(3):319-328. PubMed ID: 31863360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing Ipilimumab-Induced Hypophysitis: Challenges and Current Therapeutic Strategies.
    Tsoli M; Kaltsas G; Angelousi A; Alexandraki K; Randeva H; Kassi E
    Cancer Manag Res; 2020; 12():9551-9561. PubMed ID: 33061641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging criteria of immune checkpoint inhibitor-induced hypophysitis.
    Nada A; Bhat R; Cousins J
    Curr Probl Cancer; 2021 Feb; 45(1):100644. PubMed ID: 32888700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency and clinical characteristics of hypophysitis and hypopituitarism in patients undergoing immunotherapy - A systematic review.
    Jacques JP; Valadares LP; Moura AC; Oliveira MRF; Naves LA
    Front Endocrinol (Lausanne); 2023; 14():1091185. PubMed ID: 36875457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocytic hypophysitis. Case report.
    Naik RG; Ammini A; Shah P; Sarkar C; Mehta VS; Berry M
    J Neurosurg; 1994 May; 80(5):925-7. PubMed ID: 8169636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune checkpoint inhibitor therapy associated hypophysitis.
    Mahzari M; Liu D; Arnaout A; Lochnan H
    Clin Med Insights Endocrinol Diabetes; 2015; 8():21-8. PubMed ID: 25861234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune phenomena involving the pituitary gland in children: New developing data about diagnosis and treatment.
    Romano A; Rigante D; Cipolla C
    Autoimmun Rev; 2019 Oct; 18(10):102363. PubMed ID: 31401342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ipilimumab cystic hypophysitis mimicking metastatic melanoma.
    Wallace J; Krupa M; Brennan J; Mihlon F
    Radiol Case Rep; 2018 Jun; 13(3):740-742. PubMed ID: 29977435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of granulomatous hypophysitis with hypopituitarism and minimal pituitary enlargement.
    Hassoun P; Anayssi E; Salti I
    J Neurol Neurosurg Psychiatry; 1985 Sep; 48(9):949-51. PubMed ID: 4045491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypophysitis from immune checkpoint inhibitors: challenges in diagnosis and management.
    Kotwal A
    Curr Opin Endocrinol Diabetes Obes; 2021 Aug; 28(4):427-434. PubMed ID: 34183541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ipilimumab-induced hypophysitis: review of the literature.
    Araujo PB; Coelho MC; Arruda M; Gadelha MR; Neto LV
    J Endocrinol Invest; 2015 Nov; 38(11):1159-66. PubMed ID: 25957829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A COMMON PITUITARY AUTOANTIBODY IN TWO PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR-MEDIATED HYPOPHYSITIS: ZCCHC8.
    Leiter A; Gnjatic S; Fowkes M; Kim-Schulze S; Laface I; Galsky MD; Gallagher EJ
    AACE Clin Case Rep; 2020; 6(4):e151-e160. PubMed ID: 32671216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence of Hypophysitis After Immune Checkpoint Inhibitor Rechallenge.
    Park BC; Jung S; Wright JJ; Johnson DB
    Oncologist; 2022 Dec; 27(12):e967-e969. PubMed ID: 36288471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review.
    Oğuz SH; Ünlütürk U; Aksoy S; Erbas T
    Immunotherapy; 2021 Oct; 13(14):1157-1163. PubMed ID: 34387129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocytic Hypophysitis Mimicking Pituitary Macroadenoma.
    Ralot TK; Aggarwal J; Haniadka R; Gehlot K; Dongre N; Patil S
    J Assoc Physicians India; 2017 Apr; 65(4):85-86. PubMed ID: 28527171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocytic hypophysitis.
    Molitch ME; Gillam MP
    Horm Res; 2007; 68 Suppl 5():145-50. PubMed ID: 18174733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypophysitis: A Rare Cause of Impaired Consciousness in a Middle-Aged Woman.
    Baby N; Varghese P; Kunnathuparambil SG; Kuriakose AM
    Neurol India; 2020; 68(5):1214-1216. PubMed ID: 33109880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of autoantibodies against the pituitary-specific proteins in patients with lymphocytic hypophysitis.
    Tanaka S; Tatsumi KI; Kimura M; Takano T; Murakami Y; Takao T; Hashimoto K; Kato Y; Amino N
    Eur J Endocrinol; 2002 Dec; 147(6):767-75. PubMed ID: 12457452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.